Mar 27 |
2 Magnificent Growth Stocks With Room to Run
|
Mar 14 |
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
|
Mar 1 |
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
|
Mar 1 |
Prime Medicine GAAP EPS of -$2.18
|
Mar 1 |
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
|
Feb 29 |
14 Stocks With Heavy Insider Buying In 2024
|
Feb 28 |
Prime Medicine to Participate in Upcoming Investor Conferences
|
Feb 25 |
With 34% ownership, Prime Medicine, Inc. (NASDAQ:PRME) has piqued the interest of institutional investors
|
Feb 20 |
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
|
Feb 15 |
Prime Medicine down 5%, prices $140M stock offering
|